About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Ohio | 28,703 Studies Near You

Clinical TrialsOhio

Clinical Trials in Ohio

Discover 28,703 clinical trials near Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3441-3460 of 28,703 trials

CompletedA Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast CancerThe purpose of this study is to evaluate survival, response rate, safety and tolerability of YM155 given in combination with docetaxel as first-line treatment in subjects with…NCT01038804·Los Angeles, California and 29 others

Find Trials by Condition in Ohio

Breast Cancerin Ohio Lung Cancerin Ohio Prostate Cancerin Ohio Colorectal Cancerin Ohio Melanomain Ohio Leukemiain Ohio Lymphomain Ohio Pancreatic Cancerin Ohio Ovarian Cancerin Ohio Brain Cancerin Ohio Diabetesin Ohio

Data from ClinicalTrials.govTerms

CompletedEfficacy and Safety of Alogliptin in Subjects With Type 2 DiabetesThe purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), in adults with type 2 diabetes.NCT00286455·Birmingham, Alabama and 66 others

CompletedNovel Paradigms of Deep Brain Stimulation for Movement DisordersInvestigators will enroll patients who are already selected to undergo deep brain stimulation surgery based on standard of care.NCT04563143·Cleveland, Ohio

CompletedMultimedia Psychoeducation or Print Education in Preparing Cancer Patients for Decision Making About Clinical TrialsThis randomized clinical trial compares multimedia psychoeducation to print education in preparing patients with cancer for decision making about clinical trial participation.NCT02054715·San Diego, California and 17 others

CompletedPhase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLLThis phase II trial studies how well anti-cluster of differentiation (CD)19 monoclonal antibody MOR00208 and lenalidomide work in treating patients with relapsed, refractory, or…NCT02005289·Columbus, Ohio

CompletedA Study of LY2127399 in Participants With Systemic Lupus ErythematosusThe purpose of this SLE study is to evaluate the efficacy, safety and tolerability of two different doses of LY2127399 administered in participants with active SLE.NCT01196091·Birmingham, Alabama and 191 others

CompletedA Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice.NCT02815891·Phoenix, Arizona and 71 others

CompletedEffectiveness of a Telephone-Delivered Behavioral Treatment to Improve the Quality of Life of Older Adults With HIVThis study will evaluate the effectiveness of a telephone-delivered coping improvement group intervention in improving quality of life in older adults with HIV.NCT00365690·Athens, Ohio

RecruitingSTOP-HAE: A Phase 3 Study of ADX-324 in HAEThis study will evaluate the efficacy and safety of ADX-324 in participants with Type 1 or Type 2 hereditary angioedema.NCT06960213·Litchfield Park, Arizona and 69 others

CompletedPhase I Norovirus Challenge ModelThis is a safety and infectivity study of experimental human Norovirus genogroup GII.4 administered to 48 healthy non-pregnant adults, 18-49 years of age, negative for COVID-19 by…NCT04174560·Cincinnati, Ohio

CompletedStudy of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AIPost-menopausal women with hormone-receptor positive (HR+) metastatic breast cancer resistant to aromatase inhibitor (AI) therapy will be randomized to receive Fulvestrant…NCT01797120·Greenbrae, California and 24 others

CompletedThe Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and OlderThis is a Phase 3, randomized, parallel-group, comparator-controlled, observer-blind, multicenter study of immunogenicity and safety in approximately 7700 male and female adults…NCT06015282·Tempe, Arizona and 95 others

CompletedA follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]An open-label follow-on safety study of CDP870 (400 mg every 4 weeks) in patients with Crohn's Disease who have completed a 26-week blinded study (CDP870-031 \[NCT00152490\] or…NCT00160524·Birmingham, Alabama and 205 others

RecruitingDelivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell DiseaseIn a hybrid type I effectiveness-implementation trial, our three-center research teams aim to examine whether empowering adults with sickle cell disease (SCD) with patient-facing…NCT06919224·Chicago, Illinois and 3 others

CompletedHIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine StudyThis study evaluated the safety, immunogenicity, and preliminary assessment of efficacy of a novel vaccine encoding conserved elements (CE) of the HIV-1 Gag core protein, p24Gag…NCT03560258·Birmingham, Alabama and 14 others

CompletedAxitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney CancerAxitinib dose titration (giving a higher dose of the drug above its standard starting dose) among certain patients may improve the response to treatment.NCT00835978·Antioch, California and 64 others

CompletedA Safety and Effectiveness Trial of Spinal Cord Stimulation of the Dorsal Root Ganglion for Chronic Lower Limb PainThe purpose of this study is to evaluate the safety and effectiveness of the AXIUM Neurostimulator System for the treatment of chronic lower limb pain in persons diagnosed with…NCT01923285·Phoenix, Arizona and 21 others

CompletedSafety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type HeadacheThis is a randomized, multicenter, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of a single dose of TNX-201 (140 mg) for the…NCT02423408·San Jose, California and 9 others

RecruitingTesting the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or CarcinosarcomaThis phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo \[TM\]) to the…NCT05256225·Birmingham, Alabama and 413 others

CompletedEfficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisThe two objectives of this study were to evaluate long-term efficacy and safety of adalimumab treatment in participants who had moderate to severe chronic plaque psoriasis and to…NCT00195676·Birmingham, Alabama and 103 others

PreviousPage 173 of 1436Next

Heart Diseasein Ohio